MEIP - Fate Therapeutics names Brian Powl as chief commercial officer
- Fate Therapeutics ( NASDAQ: FATE ) has appointed Brian Powl as its new chief commercial officer .
- He was most recently SVP, commercial development & marketing at MEI Pharma ( MEIP ).
- Before then, he was VP, global commercial CAR T lead at Celgene Corp.
For further details see:
Fate Therapeutics names Brian Powl as chief commercial officer